Medical Journals Archives - Page 3 of 29

HIV drugs may lower COVID risk; COVID and flu co-infection raises risk of severe illness, death

Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, HIV, Hospitalized COVID-19 Patients, Influenza, Nasal Sprays, Protease inhibitors, R&D, SARS-CoV-2 virus, Small Molecules, The Lancet, Therapeutics

Certain drugs used to treat HIV may have a role in preventing SARS-CoV-2 infections, according to preliminary data that may help explain why people living with the condition have not appeared to be at higher risk for serious COVID-19 despite being generally more vulnerable to infections. Additionally, having COVID-19 and influenza at the same time puts hospitalized adults at much greater risk of critical illness and death compared to having COVID-19 without the flu, researchers reported in The Lancet.

March 28, 2022/by Reuters Health

Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar Gel in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context

Autoimmune Diseases, Drugs in Context, NSAIDs, Peer-Reviewed Analysis, Refractory rheumatoid arthritis (RA), Standard of care drugs, Therapeutics

Global biopharmaceutical company Mallinckrodt plc announced the publication of findings from a retrospective medical records study assessing the real-world utilization and outcomes of Acthar Gel (repository corticotropin injection) in patients with refractory rheumatoid arthritis (RA) that did not adequately respond to standard-of-care therapies.

March 28, 2022/by PR Newswire

Some immune system memory persists year after infection; COVID from Omicron also less severe for pregnant women

Antibodies, China, Coronavirus Infections, COVID-19 Studies, COVID-19 Vaccinations, Doctors, Immune System, JAMA, Omicron (B.1.1.529) (South Africa), Omicron BA.2, Pregnancies, R&D, Texas, The Lancet Microbe, Women

A year after infection with the coronavirus – when antibodies in the blood are barely detectable – the immune system continues to “remember” the virus and should respond to some extent upon re-encountering it, a study from China suggests. According to new research, women who were pregnant during the recent Omicron surge had more than eight times the rate of COVID-19 diagnoses, but lower odds of severe illness compared with pregnant women diagnosed earlier in the pandemic.

March 25, 2022/by Reuters Health

Risk of type 2 diabetes rises after COVID; organ transplant from donors who had COVID likely safe

Coronavirus Disease (COVID-19) Pandemic, COVID-19 Severe Complications, COVID-19 Studies, JAMA Psychiatry, Medical Journals, Neuropsychiatric Diseases, Organ Transplantation, R&D, Reuters, The Lancet Diabetes & Endocrinology, Type 2 Diabetes, U.S. Department of Veterans Affairs

People may be at increased risk for developing diabetes for up to a year after a diagnosis of COVID-19, according to two studies. Additionally, organ donation from dying donors with current or previous COVID-19 infection is likely safe, transplant teams from the United States and Italy will report at the April 2022 European Congress of Clinical Microbiology & Infectious Diseases meeting.

March 23, 2022/by Reuters Health

Studies Suggest Links Between COVID-19 and Diabetes, Pregnancy Risks and Dementia

Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Studies, Dementia, Diabetes, Heart Problems, JAMA Internal Medicine, Nature Medicine, Neurological Conditions, Pregnancies, R&D, The Lancet Diabetes & Endocrinology, Type 2 Diabetes, University of Iowa, University of Rochester Medical Center

The most obvious risks from COVID-19 are hospitalization and death. But study after study shows the disease comes with an increased risk of a number of health problems, including diabetes.

March 22, 2022/by BioSpace

Research Roundup: Spider Silk Stabilizes Cancer-Suppressing Protein and More

Asthma, Autism Spectrum Disorder (ASD), Cancer Cells, Cancer Therapies, Coronavirus Disease 2019 (COVID-19), Gene Mutations, Heart Attacks, Heart Disease, High Cholesterol, Karolinska Institute, Medical Journals, Parkinson's Disease, Pediatrics, Proteins, R&D, Skin test, Structure, Testing

Maybe Spider-Man was on to something. Although spider silk and synthetic forms have been used for a wide range of applications – including bullet-proof clothing, biodegradable bottles, and bandages and surgical thread – new research suggests it may have a use for cancer therapies.

March 18, 2022/by BioSpace

Omicron linked to rise in croup in babies; TB vaccine improves immune response to coronavirus

Annals of Neurology, Babies, Bacillus Calmette-Guerin (BCG) Vaccine, Coronavirus, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Studies, Croup, Data, Hospitalized COVID-19 Patients, Immune Response, Omicron (B.1.1.529) (South Africa), Pediatrics, R&D, Research, Respiratory Conditions, Toddlers, Tuberculosis, Ventilators

The Omicron variant of the coronavirus is causing a dramatic rise in cases of croup, a dangerous respiratory condition usually seen in babies and toddlers, new data suggest. Additionally, new research sheds light on how a tuberculosis vaccine might help protect against COVID-19.

March 16, 2022/by Reuters Health

One in four children with COVID-19 symptoms develop “long COVID,” according to data pooled from 21 earlier studies conducted in Europe, Asia, Australia and South America. Also, according to a study reported on March 14 in JAMA Pediatrics, women who wish to pass protective antibodies induced by COVID-19 vaccines to their babies via breast milk should opt for the mRNA shots from Moderna or Pfizer/BioNTech.

March 14, 2022/by Reuters Health

An experimental vaccine developed by GeoVax Labs Inc. succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study and was advanced to mid-stage clinical trials, researchers reported.
COVID-19 patients who receive one of the few antibody treatments that works against the Omicron variant must be carefully monitored because after the drug is infused, the virus may mutate and become resistant to it, researchers warned after seeing such cases with Delta variant patients.

March 11, 2022/by Reuters Health

Variant that combines Delta and Omicron identified; dogs sniff out virus with high accuracy

Coronavirus Infections, Covid-19 Variants, Delta Variant (B.1.617.2; India), Dogs, Europe, Genes, Journal of Clinical Immunology, Mutations, Omicron (B.1.1.529) (South Africa), Patients, R&D, United States

Hybrid versions of the coronavirus that combine genes from the Delta and Omicron variants – dubbed “Deltacron” – have been identified in at least 17 patients in the United States and Europe, researchers said. Additionally, new research adds to evidence that trained dogs could help screen crowds to identify people infected with the coronavirus.

March 9, 2022/by Reuters Health

HIV drugs may lower COVID risk; COVID and flu co-infection raises risk of severe illness, death

Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar Gel in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context

Some immune system memory persists year after infection; COVID from Omicron also less severe for pregnant women

Risk of type 2 diabetes rises after COVID; organ transplant from donors who had COVID likely safe

Studies Suggest Links Between COVID-19 and Diabetes, Pregnancy Risks and Dementia

Research Roundup: Spider Silk Stabilizes Cancer-Suppressing Protein and More

Omicron linked to rise in croup in babies; TB vaccine improves immune response to coronavirus

A quarter of symptomatic kids hit by long COVID; mRNA shots provide best protection in breast milk

GeoVax vaccine targeting virus in two places shows promise; virus may become resistant to antibody drugs

Variant that combines Delta and Omicron identified; dogs sniff out virus with high accuracy